Dried apples regulate blood sugar levels
(Natural News) Researchers from San Diego State University report that dried apples could regulate blood sugar levels and improve insulin responses in healthy people. For their study, they examined the potential of dried apples to regulate blood sugar, insulin, satiety, and total plasma antioxidant levels, as well as the effect of dried apples on cognitive... (Source: NaturalNews.com)
Source: NaturalNews.com - February 28, 2019 Category: Consumer Health News Source Type: news

Herbalist sentenced after death of diabetic boy advised not to use insulin
An herbalist has been sentenced to jail time after the death of a 13-year-old boy with Type 1 diabetes for whom he recommended treatment with herbs instead of lifesaving insulin, Los Angeles City Attorney Mike Feuer announced Monday. (Source: CNN.com - Health)
Source: CNN.com - Health - February 28, 2019 Category: Consumer Health News Source Type: news

Vegan diets can improve insulin production in people with diabetes
A plant-based diet can improve insulin secretion and incretin hormones for people with type 2 diabetes, according to a study published in the journal Nutrients. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 27, 2019 Category: Consumer Health News Source Type: news

Featured Review: Mediterranean-style diet for the prevention of cardiovascular disease
In this Q&A we asked the lead author Professor Saverio Stranges from Western University Canada to explain more about the mediterranean diet and its role in preventing cardiovascular disease following the publication of aCochrane Review on this topic. What makes a diet ‘Mediterranean’?Scientific interest in the traditional Mediterranean dietary pattern originated in the 1960s because of the observation that populations in countries of the Mediterranean region, such as Greece and Italy, had lower mortality from cardiovascular disease compared with northern European populations or the US, probably as a re...
Source: Cochrane News and Events - February 27, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

New method may improve cell transplantation to treat diabetes
A new method to track oxygen supply in implanted insulin-producing cells may help the development of improved treatments for diabetes, according to research published inProceedings of the National Academy of Sciences.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 27, 2019 Category: Endocrinology Source Type: news

Red raspberries may lower diabetes risk
Research, published inObesity, suggests that eating red raspberries may lower the risk of insulin resistance.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 27, 2019 Category: Endocrinology Source Type: news

FDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled on Oral Antidiabetic Medicines
BRIDGEWATER, N.J., Feb. 27, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved the expanded use of Soliqua 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL. Previously approved for use as an... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 27, 2019 Category: Drugs & Pharmacology Source Type: news

Plant-based meals improve insulin and incretin secretion in those with type 2 diabetes
(Physicians Committee for Responsible Medicine) A plant-based diet improves the secretion of insulin and incretin hormones in those with type 2 diabetes, according to new research published in Nutrients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 27, 2019 Category: International Medicine & Public Health Source Type: news

So, When is the GE Healthcare IPO Happening?
Don’t look for General Electric to spin out its healthcare unit just yet. The Boston, MA-based company said an IPO for its healthcare business was going to be put on hold while it sells of its pharmaceutical unit to Danaher for $21 billion. During an interview with CNBC, General Electric’s chairman and CEO said that an IPO of for GE Healthcare in 2019 is “unlikely at this point.” The firm made waves in June of 2018, when it announced it would spin out GE Healthcare. During that time, the company said the IPO could occur sometime this year. The reason b...
Source: MDDI - February 26, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Hygieia's cloud-based insulin titration app wins 510(k) clearance
The d-Nav Insulin Guidance Service  was also the focus of a multi-center, randomized control trial published last week in the Lancet. (Source: mobihealthnews)
Source: mobihealthnews - February 25, 2019 Category: Information Technology Source Type: news

IPT for Cancer Unproven, May Do Harm IPT for Cancer Unproven, May Do Harm
When a cancer patient asks about unproven therapies such as insulin-potentiation therapy (IPT), don't brush the question aside: this is a chance to provide information, say clinicians.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 25, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Glooko, Novo Nordisk team up for connected insulin pens
Glooko announced this month that it’s teaming up to connect Novo Nordisk‘s (NYSE:NVO) insulin pens with the company’s diasend diabetes management solution. Novo Nordisk plans to launch its connected insulin pens, the NovoPen 6 and NovoPen Echo Plus, in early 2019. Any provider using diasend and any person using the diasend mobile app will be able to sync data from Novo Nordisk’s connected pens, according to Glooko. Get the full story at our sister site, Drug Delivery Business News. The post Glooko, Novo Nordisk team up for connected insulin pens appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 25, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Dexcom Glooko Insulet Novo Nordisk Source Type: news

A Look at the Competitive Landscape of Diabetes Devices
Diabetes represents a huge market opportunity for medical device companies, but that also makes for a tough competitive landscape. Here we have reviewed the key players and what 2019 could have in store for them, based on recent news and earnings calls. Abbott Is on a Tear  Abbott's latest milestone in the diabetes space is a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk's pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system. The companies said that integrating the two products will enable diabetes patients, c...
Source: MDDI - February 25, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

New study shows red raspberries may help with glucose control in people with pre-diabetes
(Illinois Institute of Technology) A study released today from the Illinois Institute of Technology shows the benefits of including red raspberries in the diet of individuals with pre-diabetes and insulin resistance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 25, 2019 Category: International Medicine & Public Health Source Type: news

U.S. Senators launch bipartisan probe into rising insulin prices
Two top U.S. senators launched an investigation into rising insulin prices on Friday, sending letters to the three leading manufacturers seeking answers as to why the nearly 100-year-old drug's cost has rapidly risen, causing taxpayers to spend millions of dollars a year. (Source: Reuters: Health)
Source: Reuters: Health - February 22, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

A Guide to Improving Insulin Access for Patients With T1D A Guide to Improving Insulin Access for Patients With T1D
Dr Tridgell is an active advocate for affordable access to insulin. Here, he lays out concrete steps clinicians can take to improve insulin access for patients with type 1 diabetes.Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Article Source Type: news

First Insulin Management App Cleared; Apple vs Pear Genes
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 22, 2019 Category: American Health Source Type: news

New therapy approach may improve diabetes treatment
Research, published inCell Metabolism, suggests that eliminating damaged beta cells that can no longer produce insulin may be an effective treatment for type-1 diabetes. Independant (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 22, 2019 Category: Endocrinology Source Type: news

Nanotechnology breakthrough helps diabetics track their blood sugar levels
(Natural News) Patients with Type 1 diabetes can thank Oregon-based researchers for developing a wearable medical device that works like an artificial pancreas. 3D printed instead of built, its nano sensors keep a constant eye on blood glucose levels, so that it can deliver insulin and glucagon to the patient whenever necessary. The new device was designed by researchers... (Source: NaturalNews.com)
Source: NaturalNews.com - February 22, 2019 Category: Consumer Health News Source Type: news

New study confirms: Processed carbs cause many harmful effects on health
(Natural News) A study that was published in the Obesity issue of the American Association for Clinical Chemistry‘s journal, Clinical Chemistry, showed that people face higher risks of becoming obese if they produce higher-than-normal levels of insulin after ingesting processed carbohydrates. This finding backs the assumption that refined carbs are causing the obesity epidemic. “Americans... (Source: NaturalNews.com)
Source: NaturalNews.com - February 22, 2019 Category: Consumer Health News Source Type: news

Buying Insulin Over-the-Counter at Walmart Common Practice Buying Insulin Over-the-Counter at Walmart Common Practice
Surveys conducted with Walmart and other pharmacy chains reveal that many patients with diabetes are turning to Walmart's own, less expensive over-the-counter human insulin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 21, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Abbott, Novo Nordisk ink deal for digital diabetes tools
Abbott (NYSE:ABT) said today that it inked a non-exclusive deal to integrate insulin dose data from Novo Nordisk‘s (NYSE:NVO) pre-filled and connected pens with its FreeStyle Libre mobile app and cloud-based system. The companies touted that integrating the products will allow healthcare professionals, caregivers and users to easily view glucose and insulin data, as well as make more informed treatment decisions. Get the full story at our sister site, Drug Delivery Business News. The post Abbott, Novo Nordisk ink deal for digital diabetes tools appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Diabetes Drug-Device Combinations Featured mHealth (Mobile Health) Pharmaceuticals Wall Street Beat Abbott Novo Nordisk Source Type: news

Hygieia wins FDA clearance for insulin management app
Hygieia said today that it won 510(k) clearance from the FDA for its insulin management app designed to optimize insulin dosing among people with Type 2 diabetes. The Michigan-based company touted its product as the first insulin management mobile app that can titrate individualized doses for all types of insulin regimens. Get the full story at our sister site, Drug Delivery Business News. The post Hygieia wins FDA clearance for insulin management app appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: 510(k) Diabetes Drug-Device Combinations Featured Food & Drug Administration (FDA) mHealth (Mobile Health) Pharmaceuticals Regulatory/Compliance Hygieia Source Type: news

Novo Nordisk's new insulin pens will integrate with Abbott's Freestyle Libre system
Abbott joins Dexcom, Glooko  and Roche as a data-sharing partner for the as-yet-unlaunched device. (Source: mobihealthnews)
Source: mobihealthnews - February 20, 2019 Category: Information Technology Source Type: news

Abbott and Novo Nordisk Enter Partnership to Provide Integrated Digital Solution to People with Diabetes Using Insulin
Collaboration will enable insulin data to be shared between Novo Nordisk connected insulin pens and digital health tools compatible(i) with FreeStyle Libre portfolio of products (Source: Abbott.com)
Source: Abbott.com - February 20, 2019 Category: Pharmaceuticals Source Type: news

Hygieia Receives 510(k) Clearance from FDA for Phone App That Enhances Company's d-Nav Insulin Guidance Service
First Insulin-Management App Able to Titrate All Types of Insulin Regimens for People with Type 2 Diabetes and Connect To Any Glucose Meter That Shares Data with the Cloud LIVONIA, Mich., Feb. 20, 2019 -- (Healthcare Sales & Marketing Network) -- Hygie... Devices, Endocrinology, FDA Hygieia , insulin-management app, d-Nav Insulin Guidance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 20, 2019 Category: Pharmaceuticals Source Type: news

Safer stem cells may improve diabetes treatment
Stem cells, designed to only survive when they become insulin producing cells, may improve diabetes treatment, according to research published inStem Cell Reports. MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 20, 2019 Category: Endocrinology Source Type: news

Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLink[1] mobile app and LibreView[2] cloud-based system). (Source: World Pharma News)
Source: World Pharma News - February 20, 2019 Category: Pharmaceuticals Tags: Featured Novo Nordisk Business and Industry Source Type: news

Abbott and Novo Nordisk Enter Partnership to Provide Integrated Digital Solution to People with Diabetes Using Insulin
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLink[1] mobile app and LibreView[2] cloud-based system). (Source: eHealth News EU)
Source: eHealth News EU - February 20, 2019 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

FDA grants De Novo clearance to interoperable insulin pump
The Tandem Diabetes Care t:Slim X2 can work in tandem with other blood sugar management devices, or on its own. (Source: mobihealthnews)
Source: mobihealthnews - February 19, 2019 Category: Information Technology Source Type: news

Another Significant Milestone in the Diabetes Space
Tandem Diabetes Care has been given FDA approval for its t:slim X2 insulin pump. Through the approval, the agency has created a new device category – Alternate Controller Enabled Infusion Pumps (ACE Pumps). The San Diego-based company’s recent approval joins the list of several developments that have changed or helped reshape the diabetes market. Along with this authorization, the FDA is establishing criteria, called special controls, which outline requirements for assuring the accuracy, reliability, cybersecurity and clinical relevance of ACE pumps, as well as describe the type of studi...
Source: MDDI - February 19, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Regulatory and Compliance Source Type: news

FDA Approves First Interoperable Insulin Pump FDA Approves First Interoperable Insulin Pump
With the approval, the FDA creates a new approval pathway for alternate controller enabled infusion pumps, with newly established'special controls'to ensure safety and reliability.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 19, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Medical Device Alert: Accu-Chek ® Insight insulin pumps – some need to be fitted with key frames to reduce the risk of accidentally unlocking keys or pressing the bolus buttons
Important instructions have been provided on how to fit 2 separate key frames onto all affected Accu-Check Insight pumps (i.e. pumps with serial numbers below 32100000) to prevent accidentally activat (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 19, 2019 Category: Drugs & Pharmacology Source Type: news

Medtronic wins FDA ’s breakthrough status for closed-loop insulin system
Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system. The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic wins FDA’s breakthrough status for closed-loop insulin system appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 19, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Featured Pharmaceuticals Regulatory/Compliance Wall Street Beat Medtronic Source Type: news

Engineered 'suicide genes' prevent tumors in stem cell-derived beta cells
(Diabetes Research Institute Foundation) Scientists from the Diabetes Research Institute at the University of Miami have engineered a human pluripotent stem cell line containing two 'suicide genes' that induce cell death in all but the desired insulin-producing cells. This double fail-safe approach addresses the limitations of pluripotent stem cell-derived beta cells and opens the door to creating safe cell-replacement therapies for people living with type 1 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2019 Category: International Medicine & Public Health Source Type: news

Novo Nordisk's soon-to-be-released insulin pens will connect to Glooko's diasend platform
This morning Glooko also announced that its diasend platform will be compatible with the Dexcom G6.   (Source: mobihealthnews)
Source: mobihealthnews - February 18, 2019 Category: Information Technology Source Type: news

Americans Cross Border Into Mexico to Buy Insulin at a Fraction of US Cost Americans Cross Border Into Mexico to Buy Insulin at a Fraction of US Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Americans Going to Mexico to Buy Insulin at Fraction of US Cost Americans Going to Mexico to Buy Insulin at Fraction of US Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

FDA Approves First Customizable Insulin Pump
FRIDAY, Feb. 15, 2019 -- The Tandem Diabetes Care t:Slim X2 insulin pump, which allows a patient to customize treatment, has been approved by the U.S. Food and Drug Administration. The new device is described as either an alternate controller... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 15, 2019 Category: Pharmaceuticals Source Type: news

First Interoperable Insulin Pump OK'd; Diabetes Scam; Linagliptin CV Outcomes
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 15, 2019 Category: Cardiology Source Type: news

Could Your IoT Device Put Patients at Risk?
The Internet of Things is driving incredible innovation in healthcare. “Almost any new innovative medical device is currently designed as a part of broader interconnected system,” Rami Muleys, head of application security business development at Positive Technologies, told MD+DI. “The main value of IoT is the convergence between different systems and the ability to exchange data between every device – from an insulin pump to a hospital bed.” Healthcare is consequently “a constantly changing landscape, especially sinc...
Source: MDDI - February 15, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news

#ICYMI: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices. Read more here: https://go.usa.gov/xEUuM   #MedicalDevice #FDA
#ICYMI: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices. Read more here: https://go.usa.gov/xEUuM  #MedicalDevice #FDA (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 15, 2019 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Tandem wins interoperable claim for insulin pump from FDA
The FDA announced this week that it established Tandem Diabetes Care‘s (NSDQ:TNDM) t:slim X2 insulin pump as the first in a new category of devices called ‘Alternate Controller Enabled Infusion Pumps’ or ACE pumps. The newly-approved indication for Tandem’s t:slim X2 pump clears the device to communicate with compatible products, including insulin dosing software and continuous glucose monitors. Get the full story at our sister site, Drug Delivery Business News. The post Tandem wins interoperable claim for insulin pump from FDA appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 15, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Featured Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat tandemdiabetes Source Type: news

First Customizable Insulin Pump Approved
FRIDAY, Feb. 15, 2019 -- The Tandem Diabetes Care t-Slim X2 insulin pump, which allows a patient to customize treatment, has been approved by the U.S. Food and Drug Administration. " Diabetes is a complicated disease that requires close monitoring... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2019 Category: General Medicine Source Type: news

Type 2 diabetes: Working for this many hours per week may increase diabetes risk
TYPE 2 diabetes is caused by having too much sugar in the blood, which happens due to problems with the body ’s production of insulin. There are some risk factors which can increase the chance of this happening, and one study has revealed working for a certain number of hours per week may raise the risk. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2019 Category: Consumer Health News Source Type: news

Type 2 diabetes: Working 37.5 hours per week may increase diabetes risk, reveals study
TYPE 2 diabetes is caused by having too much sugar in the blood, which happens due to problems with the body ’s production of insulin. There are some risk factors which can increase the chance of this happening, and one study has revealed working for a certain number of hours per week may raise the risk. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2019 Category: Consumer Health News Source Type: news

The Lypla1 gene impacts obesity in a sex-specific manner
(Deutsches Zentrum fuer Diabetesforschung DZD) Susceptibility to obesity, insulin resistance and other cardio-metabolic traits may also be dependent on a person's sex. An international research team studied sex differences and sex-specific interaction with the genetic background in cardio-metabolic phenotypes. The researchers discovered, among other things, a sex-specific obesity locus of the Lypla1 gene, which is associated with human obesity. The results of the study have now been published in Cell Metabolism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2019 Category: International Medicine & Public Health Source Type: news

FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
(Source: Food and Drug Administration)
Source: Food and Drug Administration - February 14, 2019 Category: American Health Source Type: news

Can Americans travel to Mexico to buy insulin?
The cost of the drug can be significantly cheaper south of the border. (Source: ABC News: Health)
Source: ABC News: Health - February 14, 2019 Category: Consumer Health News Tags: Health Source Type: news

Why this mom traveled to Mexico for insulin
The cost of the drug can be significantly cheaper south of the border. (Source: ABC News: Health)
Source: ABC News: Health - February 14, 2019 Category: Consumer Health News Tags: Health Source Type: news